Since the initial founding of nootropics in the early 1980s there has been a great deal of discussion and speculation around whether or not the positive applications of nootropics could transfer over to those suffering from cognitive neurodegenerative disorders like Alzheimer’s and other forms of dementia.
More than 5 million people currently live with Alzheimer’s or another form of dementia and it is the 6th leading cause of death in the United States. Treatments for these ailments have not been as effective as we’d like and the number of cases of dementia increase each year.
Western medicine is more reactionary versus preventative in its approach. The cost to human life and the taxpayer are astronomical as a result. The pharmaceutical industry benefits greatly from giving medications to those suffering from dementia once there is an occurrence, but doesn’t educate the population on ways to help prevent it.
There are many natural ways to prevent early onset dementia but they’re not promoted like doctor-prescribed pharmaceuticals are. It’s important to remain vigilant when it comes to your personal health, utilizing all the knowledge and resources available.
Huperzine A has been studied for many years about a potential treatment for Alzheimer’s. In fact, in 1995 there was a double-blind study wherein 60% of 103 people showed a better memory, thinking, and other behavioral functions.
Another study was conducted in 2002 with patients with a diagnosis of probable or possible for Alzheimer’s Disease. It showed that those who took Huperzine A showed improvements in their mood, behavior and overall cognitive function.
Vinpocetine is another nootropic that shows great potential for fighting Alzheimer’s and dementia, offering promise in several studies.
In a randomized double-blind study, 203 people with mild dementia or moderate psychosyndromes were treated with Vinpocetine and showed significant improvement.
Brain-Derived Neurotrophic Factor
BDNF (brain-derived neurotrophic factor) increasing nootropics such as tianeptine, noopept, and semax, have all been shown to aid in preventing neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This is because BDNF plays a significant role in neurogenesis—promoting protective pathways within the brain and enhancing cell survival.
Piracetam and Choline
Piracetam was originally developed to treat chronic neurodegenerative disorders. Noopept has been shown to improve cognitive deficiency in rats. The Cholinergic system along with its main neurotransmitter, acetylcholine, helps focus, memory, learning, and sensory perception. It’s naturally found in our diet but we don’t consume enough so there are many folks with deficiencies.
Choline supplements such as Alpha GPC, Citicoline, and others prevent this deficiency. Pramiracetam, choline bitartrate, coluracetam, phenylpiracetam, and others help regulate acetylcholine levels.
Although there are studies that back the idea that nootropics benefit those fighting against dementia and Alzheimer’s, It’s early to recommend or advise that these nootropics are a sure way to eliminate dementia and Alzheimer’s, but the studies so far are promising.